In bronchial epithelial cells, AhR agonists led to the upregulation of MMP2, MMP9, and MMP1 and proposed to contribute to airway remodeling in asthma and chronic obstructive pulmonary disease [37]. This evidence concerns the gene MMP2 and chronic obstructive pulmonary disease.